Filter Content:

News

EMJ

29 Apr 2016

New Mechanisms of Bladder Function Offer Target for Therapy

SENSORY nerve activity mediating the function of the bladder is influenced by both filling pressure and newly discovered ‘non-voiding transient…

EMJ

29 Apr 2016

Glycotope Appoints Dr. Alfredo Zurlo as Chief Medical Officer

Berlin, Germany, April 29, 2016 – Glycotope GmbH, a clinical-stage immuno-oncology company built on world-leading glyco-biology expertise, today…

EMJ

29 Apr 2016

Neurological Expertise Crucial to Deal with Devastating Zika Consequences

London, 28 April 2016 — “The Zika virus is more and more showing its ugly face, and the international community increasingly realises the dimensions of…

EMJ

27 Apr 2016

MedDay appoints Catherine Moukheibir as Chairman of its Board of Directors

Paris, France, 27 April 2016 – MedDay, a biotechnology company focused on the treatment of nervous system disorders, today announces the appointment of…

EMJ

27 Apr 2016

Celyad Receives Certification for C-Cure® Non-Clinical Data from the European Medicines Agency (EMA)

C-Cure® (C3BS-CQR-1) is a cardiovascular lineage-committed cell therapy product being developed for the treatment of ischemic heart failure

EMJ

26 Apr 2016

Introducing EMJ Urology 4.1

United Kingdom, April 21, 2016: This edition of the EMJ Urology eJournal, as in previous editions, is full of the latest news, reviews, interviews, and…

EMJ

25 Apr 2016

Physical Exercise Combats Depression Post Heart Attack

UNIQUE data has shed light on the mental health of individuals who have experienced a heart attack. The analysis, which used the data collected from…

EMJ

25 Apr 2016

Functional Cardiac Muscle Cells can be Successfully Regenerated

BIOENGINEERED human hearts are becoming a reality after a team of researchers successfully generated cardiomyocytes (cardiac muscle cells)…

Loading posts...

« Previous 1 … 650 651 652 653 654 … 870 Next »